Given the high expression rate in mature T-cell lymphomas and Hodgkin lymphoma [17,68], CD30 expression has also been evaluated in ENKTL and was found to be around 50–70% [17,65,69,70]. This evidence concerns the gene TNFRSF8 and T-cell non-Hodgkin lymphoma.